The pharmaceutical giant is slashing 11% of its workforce as it continues to lose market share. Novo Nordisk, the Danish ...

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.

An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as ...

Ohio is taking steps to more tightly regulate how some large drug-compounding pharmacies in the state operate, including ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Eli Lilly said on Tuesday that its daily weight loss pill helped patients lose weight, specifically those with obesity and ...

Eli Lilly is on track to release orforglipron next year, which has showed an average of 12 percent weight loss.

Eli Lilly announced this week that its new weight-loss pill, orforglipron, cleared its latest Phase 3 trial, bringing it closer to potential Food and Drug Administration (FDA) approval. Compared with ...

Eli Lilly ( LLY -2.24%) stock has soared in the triple digits over the past three years thanks to one particular product line ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...